Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-11-27, Stock:NVS, The news for the past five days is as follows:
2019-11-20: NEWS1: Charity to pay $4 million to resolve U.S. pharma kickback probe.NEWS2: Charity to pay $4 million to resolve U.S. pharma kickback probe.NEWS3: Charity to pay $4 million to resolve U.S. pharma kickback probe.NEWS4: Novartis Is Moving Higher on the Charts, Go Long or Add to Longs.NEWS5: Medicines Company Up on Rumors of Potential Buyout by Novartis.NEWS6: Keytruda researcher launches cancer-focused Werewolf Therapeutics with $56M.
2019-11-21: NEWS1: Biogen, Novartis named in settlement between foundation, federal prosecutors.NEWS2: The Medicines Company Soars Amid Acquisition Whispers.NEWS3: ISS Global A/S -- Moody's changes outlook on ISS's Baa2 ratings to negative from stable.
2019-11-22: NEWS1: Pfizer Is the Dow’s Worst Stock. A New Strategy Makes It Worth Another Look..NEWS2: Pharma Stock Roundup: FDA Nod to NVS' & AZN's Drugs, BMY-CELG Merger Closes.
2019-11-25: NEWS1: Roche's NDA for SMA Drug Risdiplam Gets Priority Review.NEWS2: Novartis buys The Medicines Co in $9.7B deal.NEWS3: ROSEN, A GLOBAL LAW FIRM, Continues to Investigate Securities Claims Against Novartis AG – NVS.NEWS4: ROSEN, A GLOBAL LAW FIRM, Continues to Investigate Securities Claims Against Novartis AG – NVS.NEWS5: ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of The Medicines Company.NEWS6: SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of The Medicines Company to Novartis AG is Fair to Shareholders.NEWS7: Novartis Confirms Deal To Acquire Medicines Company For $9.7B.NEWS8: The ‘great rotation’ will arrive in 2020 and bring another strong year for stocks, JP Morgan says.NEWS9: Why The Novartis-Medicines Deal Is A Boon For These Biotech Stocks.NEWS10: Novartis' Takeover Of Medicines Puts The Spotlight On These Biotechs.NEWS11: A Day of Mergers: TIF, AMTD, MDCO & More.NEWS12: Biggest Merger Monday in Awhile: TIF, AMTD, MDCO & More.NEWS13: Novartis’s Deal for Medicines Company Is Good News for 2 More Stocks.NEWS14: Novartis (NVS) to Acquire The Medicines Company for $9.7B.NEWS15: Novartis to Pay $9.7 Billion in Latest Bet on New Technology.NEWS16: The Medicines Company to be Acquired by Novartis for $9.7B.NEWS17: Novartis Is Buying The Medicines Company for $9.7 Billion.NEWS18: Dow Jones Futures Signal Stock Market Rally On China, 3 Big Takeover Deals; Tesla Cybertruck Reservations Hit 200,000.NEWS19: Roche eyes quick FDA approval in SMA race with Biogen, Novartis.NEWS20: [video]Novartis Reaches $9.7 Billion Deal to Buy Cholesterol Drugmaker Medicines Co..NEWS21: UPDATE 1-Roche eyes quick FDA approval in SMA race with Biogen, Novartis.NEWS22: Tiffany, Schwab, Novartis, 'Frozen 2,' Jerome Powell - 5 Things You Must Know.NEWS23: Tiffany, Novartis, 'Frozen 2,' Palo Alto, Jerome Powell - 5 Things You Must Know.NEWS24: Novartis/Medco: the fat of the lands.NEWS25: Novartis Reaches $9.7 Billion Deal to Buy Cholesterol Drug Maker Medicines Co..NEWS26: Dow Jones Futures Rise In Fearless Stock Market Rally: Tesla Cybertruck Reservations Hit 200,000; Takeover Deals In Focus.NEWS27: Novartis takes on Sanofi, Amgen with $9.7 billion takeover of heart drug maker.NEWS28: Here is the 22nd Most Popular Stock Among 752 Hedge Funds.NEWS29: PRESS DIGEST-Financial Times - Nov 25.NEWS30: Dow Jones Futures: Stock Market Rally Still Fearless; Tesla Cybertruck Reservations, Takeover Deals In Focus.
2019-11-26: NEWS1: This Biotech Broke Out Bullishly — But Couldn't Hold Onto That Gain.NEWS2: A new Sickle cell disease drug holds much promise but most sufferers won’t be able to afford it.NEWS3: A new Sickle cell disease drug holds much promise but most sufferers won’t be able to afford it.NEWS4: Global Blood Therapeutics stock is up on sickle cell therapy approval.NEWS5: Novartis Securities Investment Ltd -- Moody's affirms Novartis' A1 rating; stable outlook.NEWS6: 4 Big Drug Stocks Ripe for Takeover After NVS-MDCO Deal.NEWS7: Top 5 Things to Know in the Market on Tuesday.

Answer: Rise